Doctor at Kocaeli University, Turkey.
Dr. Merve Gulsen Bal Albayrak is a medical biologist and molecular geneticist with expertise in proteomics-driven investigations of cancer and neurodegenerative diseases. Her research focuses on understanding disease mechanisms at the molecular level, particularly through proteomic analyses of cancer cell lines and neurodegenerative models. She has played active roles in projects funded by TÜBİTAK, TÜSEB, and university-supported initiatives. Dr. Bal Albayrak is fluent in English (C2 level) and has complemented her academic background with certifications in Good Laboratory Practice, animal experimentation, and trainer education. She continues to integrate multidisciplinary techniques into her research, contributing to the advancement of translational medical science.
Publication Profile
Scopus
Orcid
Google Scholar
Educational Details
-
Ph.D. in Basic Medical Sciences, Kocaeli University, Faculty of Medicine, Turkey (2016–2022)
-
M.Sc. in Basic Medical Sciences, Ankara University, Faculty of Medicine, Turkey (2014–2016)
-
B.Sc. in Molecular Biology and Genetics, İhsan Doğramacı Bilkent University, Faculty of Science, Turkey (2009–2014)
Professional Experience
Since 2016, Dr. Merve Gulsen Bal Albayrak has been working as a Research Assistant at Kocaeli University, Faculty of Medicine, Department of Basic Medical Sciences. Her professional journey includes significant involvement in numerous national and institutional research projects, particularly in the fields of proteomics, cancer biology, and neurodegenerative diseases. In addition to her domestic academic engagements, she has conducted research internationally at Seoul National University, South Korea, and has participated in global scientific events such as the European Society of Human Genetics (ESHG) conference. She has received specialized training in Good Laboratory Practice (GLP), animal experimentation, and education management and planning.
Research Interest
-
Medical Biology
-
Molecular Biology and Genetics
-
Proteomics and Omics Technologies
-
Cancer Biology and Cancer Stem Cells
-
Neurodegenerative Diseases
- Health Sciences
-
Cellular Signaling Pathways (Autophagy, Apoptosis, Hippo Signaling, Parthanatos)
- Natural Sciences
Author Metrics
-
Total Publications: 54
-
Citations:
-
Web of Science (WoS): 19
-
Scopus: 25
-
H-Index:
-
Web of Science (WoS): 3
-
Scopus: 3
Top Noted Publication
-
Tissue proteome analysis revealed an association between cancer, immune system response, and idiopathic granulomatous mastitis
M.G.B. Albayrak, T. Simsek, M. Kasap, G. Akpinar, N.Z. Canturk, S.A. Guler
Medical Oncology, 39(12): 238, 2022.
Citations: 17
-
An experimental workflow for enrichment of low abundant proteins from human serum for the discovery of serum biomarkers
M. Sarihan, M.G.B. Albayrak, M. Kasap, G. Akpinar, E. Kocyigit
Journal of Biological Methods, 10: e99010001, 2023.
Citations: 8
-
Comparison of before versus after intravitreal bevacizumab injection, growth factor levels and fibrotic markers in vitreous samples from patients with proliferative diabetic retinopathy
F. Ozer, E.O. Tokuc, M.G.B. Albayrak, G. Akpinar, M. Kasap, V.L. Karabas
Graefe’s Archive for Clinical and Experimental Ophthalmology, 2022.
Citations: 7
-
Elucidation of the changes occurring at the proteome level in ovaries of high‐fat diet‐induced obese rats
H.U. Simsek, M.G.B. Albayrak, M. Kasap, T. Simsek, G. Akpinar, S.A. Guler, et al.
Cell Biochemistry and Function, 40(3): 278–297, 2022.
Citations: 6
-
Downregulated GPD1 and MAGL protein levels as potential biomarkers for the metastasis of triple‑negative breast tumors to axillary lymph nodes
T. Simsek, M.G. Bal Albayrak, G. Akpinar, N.Z. Canturk, M. Kasap
Oncology Letters, 27(1): 34, 2023.
Citations: 4
Conclusion
Dr. Merve Gulsen Bal Albayrak is highly suitable for the Research for Young Scientist Award.
Her excellent academic background, strong research productivity, impactful work on cancer proteomics, and multidisciplinary approach to biomedical sciences make her a competitive candidate. She exhibits all the hallmarks of a rising leader in translational cancer research.
Although there is room for strengthening her citation impact and international partnerships, her achievements to date clearly demonstrate her potential to make major contributions to medical science.
In summary, Dr. Bal Albayrak is an outstanding young scientist who deserves serious consideration for the award.